Last updated on June 2020

Evaluation of S-600918 in Adults With Refractory Chronic Cough

Brief description of study

The primary objective of this study is to determine the optimal dose of S-600918 in patients with refractory chronic cough by evaluating the change from baseline in 24-hour cough frequency (coughs per hour) with S-600918 compared with placebo.

Clinical Study Identifier: NCT04110054

Find a site near you

Start Over

Alliance for Multispecialty Research

Tempe, AZ United States
  Connect »

Pulmonary Associates

Phoenix, AZ United States
  Connect »

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.